• Je něco špatně v tomto záznamu ?

Effects of resveratrol pretreatment on tert-butylhydroperoxide induced hepatocyte toxicity in immobilized perifused hepatocytes: involvement of inducible nitric oxide synthase and hemoxygenase-1

D Cerny, NK Canova, J Martinek, A Horinek, E Kmonickova, Z Zidek, H Farghali

. 2009 ; 20 (1) : 1-8.

Jazyk angličtina Země Spojené státy americké

Perzistentní odkaz   https://www.medvik.cz/link/bmc11006734

Grantová podpora
NR9379 MZ0 CEP - Centrální evidence projektů

The aim of this work was to study the effects of resveratrol (RES) as compared to silymarin (SM) pretreatments on tert-butylhydroperoxide (tBH) induced apoptotic/necrotic markers in hepatocytes. Hepatocyte in cultures (48 h) and in perifused immobilized agarose threads (5h) were used as cellular systems. Hepatocyte apoptosis was estimated morphologically using Annexin-V combined with propidium iodide, or toluidine blue staining. Hepatocyte viability and functionality were evaluated by ALT and urea synthesis. Nitric oxide (NO) and carbon monoxide involvements were also examined. Resveratrol and silymarin reduced tBH-induced hepatocyte toxic effects in short term experiments (5h) as measured by a significant reduction in ALT and NO increase produced by tBH. Both inducible nitric oxide synthase (NOS-2) and hemoxygenase-1 (HO-1) gene expression were increased by tBH and reduced by both RES and SM pretreatments. Morphologically, there were ameliorations in both apoptotic and necrotic markers under RES treatment and were similar to biochemical findings. In addition, RES improved hepatocyte stability in both cellular systems. It may be concluded that resveratrol and sylimarin ameliorative effects on tBH hepatocyte toxicity are comparable; involve NOS-2 and HO-1 expression and should be re-evaluated in various in vitro and in vivo experimental conditions.

000      
03416naa 2200529 a 4500
001      
bmc11006734
003      
CZ-PrNML
005      
20140327105516.0
008      
110405s2009 xxu e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Černý, Dalibor $7 jx20101201018
245    10
$a Effects of resveratrol pretreatment on tert-butylhydroperoxide induced hepatocyte toxicity in immobilized perifused hepatocytes: involvement of inducible nitric oxide synthase and hemoxygenase-1 / $c D Cerny, NK Canova, J Martinek, A Horinek, E Kmonickova, Z Zidek, H Farghali
314    __
$a Institute of Pharmacology, 1st Faculty of Medicine, Charles University, Albertov 4, 128 00 Prague 2, Czech Republic.
520    9_
$a The aim of this work was to study the effects of resveratrol (RES) as compared to silymarin (SM) pretreatments on tert-butylhydroperoxide (tBH) induced apoptotic/necrotic markers in hepatocytes. Hepatocyte in cultures (48 h) and in perifused immobilized agarose threads (5h) were used as cellular systems. Hepatocyte apoptosis was estimated morphologically using Annexin-V combined with propidium iodide, or toluidine blue staining. Hepatocyte viability and functionality were evaluated by ALT and urea synthesis. Nitric oxide (NO) and carbon monoxide involvements were also examined. Resveratrol and silymarin reduced tBH-induced hepatocyte toxic effects in short term experiments (5h) as measured by a significant reduction in ALT and NO increase produced by tBH. Both inducible nitric oxide synthase (NOS-2) and hemoxygenase-1 (HO-1) gene expression were increased by tBH and reduced by both RES and SM pretreatments. Morphologically, there were ameliorations in both apoptotic and necrotic markers under RES treatment and were similar to biochemical findings. In addition, RES improved hepatocyte stability in both cellular systems. It may be concluded that resveratrol and sylimarin ameliorative effects on tBH hepatocyte toxicity are comparable; involve NOS-2 and HO-1 expression and should be re-evaluated in various in vitro and in vivo experimental conditions.
650    _2
$a alanintransaminasa $7 D000410
650    _2
$a analýza rozptylu $7 D000704
650    _2
$a zvířata $7 D000818
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a kultivované buňky $7 D002478
650    _2
$a imobilizované buňky $7 D018914
650    _2
$a cytoprotekce $7 D019610
650    _2
$a hemoxygenasa-1 $x metabolismus $7 D051547
650    _2
$a hepatocyty $x metabolismus $x účinky léků $x ultrastruktura $7 D022781
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a oxid dusnatý $x metabolismus $7 D009569
650    _2
$a synthasa oxidu dusnatého, typ II $x metabolismus $7 D052247
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
650    _2
$a silymarin $x farmakologie $7 D012838
650    _2
$a stilbeny $x farmakologie $7 D013267
650    _2
$a nádorové biomarkery $x metabolismus $7 D014408
650    _2
$a terc-butylhydroperoxid $x toxicita $7 D020122
650    _2
$a financování organizované $7 D005381
700    1_
$a Kutinová-Canová, Nikolína $7 xx0103768
700    1_
$a Martínek, Jindřich, $d 1938-2018 $7 jn20000710438
700    1_
$a Hořínek, Aleš, $d 1961- $7 xx0061416
700    1_
$a Kmoníčková, Eva, $d 1962- $7 jo2002105217
700    1_
$a Zídek, Zdeněk $7 jk01152582
700    1_
$a Farghali, Hassan
773    0_
$t Nitric Oxide $w MED00004882 $g Roč. 20, č. 1 (2009), s. 1-8
910    __
$a ABA008 $b x $y 7 $z 0
990    __
$a 20110412125811 $b ABA008
991    __
$a 20140327105551 $b ABA008
999    __
$a ok $b bmc $g 834358 $s 698850
BAS    __
$a 3
BMC    __
$a 2009 $b 20 $c 1 $d 1-8 $m Nitric oxide $n Nitric oxide $x MED00004882
GRA    __
$a NR9379 $p MZ0
LZP    __
$a 2011-4B/ewme

Najít záznam